GlaxoSmithKline to reopen plant where Legionnaires' found

Drugmaker GlaxoSmithKline plans to resume operations at a North Carolina plant that closed after discovery of bacteria that cause Legionnaires' disease, a potentially fatal form of pneumonia.

GSK said in a statement Friday the plant in Zebulon that produces inhaled medications will reopen Monday. It had closed Aug. 11 after testing found the bacteria in cooling towers.

The London-based company said the towers have been cleaned and disinfected. About 400 employees were told to stay away until the towers were cleaned.

The same found in water tanks in the Bronx section of New York City caused 12 Legionnaires' disease deaths this summer. The Centers for Disease Control and Prevention says about 8,000 to 18,000 Americans are hospitalized with the illness annually.


Explore further

Drugmaker Glaxo shuts down plant over Legionnaires' bacteria

© 2015 The Associated Press. All rights reserved.

Citation: GlaxoSmithKline to reopen plant where Legionnaires' found (2015, August 14) retrieved 22 July 2019 from https://medicalxpress.com/news/2015-08-glaxosmithkline-reopen-legionnaires.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
14 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more